These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9344322)

  • 21. Large institutional experience with dose-intensive chemotherapy and stem cell support in the management of sarcoma patients.
    Kasper B; Dietrich S; Mechtersheimer G; Ho AD; Egerer G
    Oncology; 2007; 73(1-2):58-64. PubMed ID: 18334832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The management of patients with uterine sarcoma: a debated clinical challenge.
    Gadducci A; Cosio S; Romanini A; Genazzani AR
    Crit Rev Oncol Hematol; 2008 Feb; 65(2):129-42. PubMed ID: 17706430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Indication of chemotherapy according to histological type of musculoskeletal sarcomas].
    Goto T; Okuma T; Ogura K; Imanishi J; Hozumi T; Kondo T
    Gan To Kagaku Ryoho; 2009 Feb; 36(2):199-203. PubMed ID: 19223736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Caffeine-potentiated chemotherapy and conservative surgery for high-grade soft-tissue sarcoma.
    Tsuchiya H; Tomita K; Yamamoto N; Mori Y; Asada N
    Anticancer Res; 1998; 18(5B):3651-6. PubMed ID: 9854472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase III trial of two investigational schedules of ifosfamide compared with standard-dose doxorubicin in advanced or metastatic soft tissue sarcoma: a European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study.
    Lorigan P; Verweij J; Papai Z; Rodenhuis S; Le Cesne A; Leahy MG; Radford JA; Van Glabbeke MM; Kirkpatrick A; Hogendoorn PC; Blay JY;
    J Clin Oncol; 2007 Jul; 25(21):3144-50. PubMed ID: 17634494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The value of adjuvant chemotherapy in the management of sarcomas in children.
    Donaldson SS
    Cancer; 1985 May; 55(9 Suppl):2184-97. PubMed ID: 3884137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemotherapy for soft-tissue sarcomas.
    Elias AD
    Clin Orthop Relat Res; 1993 Apr; (289):94-105. PubMed ID: 8472436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical patterns of soft-tissue sarcoma in children].
    Méndez R; Arnáiz S; Montero M; Tellado M; País E; Ríos J; Vela D
    Cir Pediatr; 2001 Jan; 14(1):14-20. PubMed ID: 11339112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adjuvant chemotherapy for soft tissue sarcomas.
    Ravi V; Patel S
    Surg Oncol Clin N Am; 2012 Apr; 21(2):243-53. PubMed ID: 22365517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative chemotherapy and split-course radiation therapy for patients with localized soft tissue sarcomas: home run, base hit, or strike out?
    Pisters PW
    J Clin Oncol; 2006 Feb; 24(4):549-51. PubMed ID: 16446327
    [No Abstract]   [Full Text] [Related]  

  • 31. Chemotherapy in adult soft tissue sarcoma.
    Jain A; Sajeevan KV; Babu KG; Lakshmaiah KC
    Indian J Cancer; 2009; 46(4):274-87. PubMed ID: 19749457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-risk soft tissue sarcoma: clinical trial and hyperthermia combined chemotherapy.
    Issels RD
    Int J Hyperthermia; 2006 May; 22(3):235-9. PubMed ID: 16754344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histologic alterations from neoadjuvant chemotherapy in high-grade extremity soft tissue sarcoma: clinicopathological correlation.
    Lucas DR; Kshirsagar MP; Biermann JS; Hamre MR; Thomas DG; Schuetze SM; Baker LH
    Oncologist; 2008 Apr; 13(4):451-8. PubMed ID: 18448561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significant clinical benefit of first-line palliative chemotherapy in advanced soft-tissue sarcoma: retrospective analysis and identification of prognostic factors in 488 patients.
    Karavasilis V; Seddon BM; Ashley S; Al-Muderis O; Fisher C; Judson I
    Cancer; 2008 Apr; 112(7):1585-91. PubMed ID: 18278813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-dose therapy for adult soft tissue sarcoma: dose response and survival.
    Elias AD
    Semin Oncol; 1998 Apr; 25(2 Suppl 4):19-23; discussion 45-8. PubMed ID: 9578058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial.
    Trimbos JB; Vergote I; Bolis G; Vermorken JB; Mangioni C; Madronal C; Franchi M; Tateo S; Zanetta G; Scarfone G; Giurgea L; Timmers P; Coens C; Pecorelli S;
    J Natl Cancer Inst; 2003 Jan; 95(2):113-25. PubMed ID: 12529344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors.
    Carli M; Colombatti R; Oberlin O; Bisogno G; Treuner J; Koscielniak E; Tridello G; Garaventa A; Pinkerton R; Stevens M
    J Clin Oncol; 2004 Dec; 22(23):4787-94. PubMed ID: 15570080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence-based recommendations for local therapy for soft tissue sarcomas.
    Pisters PW; O'Sullivan B; Maki RG
    J Clin Oncol; 2007 Mar; 25(8):1003-8. PubMed ID: 17350950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Sarcoma Meta-analysis Collaboration.
    Lancet; 1997 Dec; 350(9092):1647-54. PubMed ID: 9400508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival improvement in resectable non-small cell lung cancer with (neo)adjuvant chemotherapy: results of a meta-analysis of the literature.
    Berghmans T; Paesmans M; Meert AP; Mascaux C; Lothaire P; Lafitte JJ; Sculier JP
    Lung Cancer; 2005 Jul; 49(1):13-23. PubMed ID: 15949586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.